Access is restricted to registered users.
If you have already registered, then log into your ECME Profile to access this course.
Preventing Atherosclerotic Cardiovascular Disease:
Where Primary Care meets Guidelines
General Course Information
The intent of this virtual real-time CME is to delve into current dyslipidemia guidelines and explore complex, challenging cases experienced by primary care providers in the context of CVD risk reduction. Participants will engage in stimulating discussions about the intersect between guidelines and practice, how to address unusual cases, and apply a nuanced approach to management.
To download the program schedule, click here.
This virtual conference will be held using Zoom. You can find the link to the virtual room on this page closer to the conference date.
Upon completion of this virtual real-time CME event, participants will be able to:
- Identify the value of completing CVD risk assessments using Enhanced Lipid Reporting (ELR) for your patient panel,
- Recognize the nuances of current dyslipidemia guidelines to confidently apply them within your practice,
- Describe available laboratory tests, their utilization, and interpretation of the results.
- Effectively discuss CVD risk scores and appropriate interventions with your patients leading to enhanced engagement promoting shared decision making,
- Recognize unique conditions, such as hypertension in pregnancy, requiring specialized CVD risk identification and management.
This course will be of interest to all Alberta-based primary care physicians interested in learning more about the current dyslipidemia guidelines.
This course will also serve the learning needs of other healthcare practitioners including nurse practitioners and pharmacists that are working with patients having cardiovascular disease risk factors.
This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the University of Calgary Office of Continuing Medical Education and Professional Development for up to 1.5 Mainpro+® credits.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 1.5 hours (credits are automatically calculated).
Jennifer Terpstra MPH, PhD (Co-Chair)
- Disclosures: co-lead on HIIS grant for this CME
Todd Anderson MD (Co-Chair)
- Disclosures: N/A
Glen Pearson BSc, BScPhm, PharmD, FSCHP, FCCS
- Disclosures: Honoraria – Novartis; Novo Nordisk. Honoraria for AIM‐LO (ASCVD Identification and Management of Lipid LOwering Therapy) QI Program/Medical Practice Assessment planning committee member. Membership on advisory boards or speakers’ bureau – HLS Therapeutics; Novartis; Novo Nordisk; Pharmascience; Trimedic Therapeutics
Janet Craig MD, CCFP, FCFP
- Disclosures: Honoraria (for Consulting) – AMA-ACTT; University of Calgary; University of Alberta; Edmonton West PCN.
Katrina (Tina) Nicholson MD, MBChB, CCFP, FCFP
- Disclosures: Honoraria – University of Calgary , Offices of CME /PD and PLP (Medical Director , CLinical Associate Professor); REACH/CanREACH (Faculty teacher);
CADDRA (Board member , Education committee member); Calgary Foothills PCN (Physician Champion, Child and Youth case collaborative); Medicine SCN (Member of core committee and Kidney health committee). Speaker’s bureau – Elvium.
Lisa Stevenson MD CCFP
- Disclosures: N/A
Carolyn Walker RN BN
- Disclosures: N/A
Utkarsh Subnis PhD, MBBS (CME Representative)
- Disclosures: N/A
Todd Anderson MD
- Disclosures: N/A
Glen Pearson BSc, BScPhm, PharmD, FSCHP, FCCS
- Disclosures: Honoraria – Novartis; Novo Nordisk. Honoraria for AIM‐LO (ASCVD Identification and Management of Lipid LOwering Therapy) QI Program/Medical Practice Assessment planning committee member. Membership on advisory boards or speakers’ bureau – HLS Therapeutics; Novartis; Novo Nordisk; Pharmascience; Trimedic Therapeutics
Janet Craig MD, CCFP, FCFP
- Disclosures: Honoraria (for Consulting) – AMA-ACTT; University of Calgary; University of Alberta; Edmonton West PCN.
Kara Nerenberg MD, FRCPC
- Disclosures: Honoraria – Alberta Health Services and University of Calgary (Clinician-Scientist); Clinical Trials (Research Funding): Heart & Stroke Foundation of Canada, CIHR
Katrina (Tina) Nicholson MD, MBChB, CCFP, FCFP
- Disclosures: Honoraria – University of Calgary , Offices of CME /PD and PLP (Medical Director , CLinical Associate Professor); REACH/CanREACH (Faculty teacher);
CADDRA (Board member , Education committee member); Calgary Foothills PCN (Physician Champion, Child and Youth case collaborative); Medicine SCN (Member of core committee and Kidney health committee). Speaker’s bureau – Elvium.
Lisa Stevenson MD CCFP
- Disclosures: N/A
Course DeliveryKiyana Madani, Education Co-ordinatorkiyana.madani@ucalgary.ca
Course DevelopmentUtkarsh Subnis, Education Consultantutkarsh.subnis@ucalgary.ca
Speaker Bios
Learn more about the speakers presenting at this course.
Dr. Glen Pearson is a Professor of Medicine in the Department of Medicine, Division of Cardiology at the University of Alberta. He is the Medical Co-Director of the Cardiac Transplant Clinic at the Mazankowski Alberta Heart Institute. He is the current Chair of Health Research Ethics Board (HREB; Biomedical Panel) for the University of Alberta. He teaches in the Cardio-Renal Block of the first Medical Practice course for medical and dental students. He also lectures in cardiovascular pharmacotherapeutics to the both the undergraduate and graduate health professions students at the University of Alberta (PharmD, MD, and MSc/PhD graduate programs). He also has an active interest in practice-based research. He has been a member of the Canadian Dyslipidemia Guidelines primary panel since 2009 and was the Co-Chair for the 2021 CCS Dyslipidemia Guidelines update. He was a primary panel member of the CCS 2018 CCS Position Statement on Familial Hypercholesterolemia (FH).
Dr. Janet Craig is a family physician in Edmonton and does some consulting to promote family medicine.
Dr. Kara Nerenberg is an Associate Professor and Clinician-Scientist at the University of Calgary working in the areas of
General Internal Medicine and Obstetric Medicine. Dr. Nerenberg’s clinical and research interests focus prevention of
cardiovascular diseases in women after common reproductive events, mainly the hypertensive disorders of pregnancy.
A UK trained family physician, Dr Nicholson has practiced in Calgary and Cochrane since 2006, currently running a small generalist panel with special areas of focused practice in women’s health and child, youth and emerging adult mental health.
Medical Education has been a special interest throughout her career – and her current roles as a Clinical Associate Professor with the Department of Family Medicine and a Medical Director for the Physician Learning Program and CME /PD offices at the Cumming School of Medicine, University of Calgary, has led to involvement in developing continuing medical education opportunities that may lead to better patient outcomes through supporting clinicians in personalized practice improvement. She has been involved in the development and chairing of numerous courses, and enjoys facilitating peer to peer interactive CME.
Her involvement with teaching and supporting REACH and CANREACH programmes has led to a passionate interest in broadening education and capacity for identifying and supporting youth struggling with mental health and neurodivergence.
Over the last 13 years , she has held various leadership roles within her PCN and is a strong advocate for a streamlined multidisciplinary approach to patient care.
Family Physician in Calgary with a passion for CME and bringing the family doctor perspective to pathway and guideline development.
Dr. Todd Anderson is a Professor of Cardiac Sciences at the University of Calgary. He is the Dean of the Cumming School of Medicine.
Dr. Anderson was awarded his medical degree from the University of Calgary in 1985 and then undertook residency training in Internal Medicine, Cardiology and Interventional Cardiology in Calgary. He pursued further research training in coronary physiology at the Brigham and Women’s Hospital at Harvard Medical School and then returned to Calgary. He has been on staff since 1995. His research interests are in cardiovascular prevention, lipid management and women’s CV health.